SCHEMBL6315929

SCHEMBL6315929

Nc1onc(-c2coc3ccccc23)c1C(=O)NC1CCc2ccccc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 1/20 0.46
LMNA P02545 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
MAPT P10636 1/20 0.43
ADORA2A P29274 1/20 0.42
TSHR P16473 1/20 0.42
TAS1R3 Q7RTX0 5/20 0.41
TAS1R1 Q7RTX1 5/20 0.41
TAS1R2 Q8TE23 5/20 0.41
ALDH1A1 P00352 2/20 0.39
NPSR1 Q6W5P4 1/20 0.39
KDM4E B2RXH2 1/20 0.39
PDE2A O00408 1/20 0.39
HTT P42858 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
MLLT3 P42568 1/20 0.39
MLLT1 Q03111 1/20 0.39
PDE4A P27815 1/20 0.38
PDE4B Q07343 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6316864 0.94 RECQL (0.53) RECQLLMNASMN1; SMN2MAPTTSHR
SCHEMBL6320666 0.82 MAOB (0.49) SMN1; SMN2TSHRALDH1A1NPSR1KDM4E
SCHEMBL6316445 0.82 MAOB (0.52) SMN1; SMN2MAPTTSHRALDH1A1NPSR1
SCHEMBL6322682 0.81 MAOB (0.54) SMN1; SMN2ALDH1A1KDM4EHTTNPC1
SCHEMBL6325219 0.81 MAOB (0.54) SMN1; SMN2ALDH1A1KDM4EHTTNPC1
SCHEMBL6319067 0.81 RECQL (0.51) RECQLLMNAADORA2ATSHRTAS1R3
SCHEMBL6316840 0.79 RECQL (0.49) RECQLADORA2ATSHRTAS1R3TAS1R1
SCHEMBL6316268 0.79 RECQL (0.48) RECQLLMNATSHRTAS1R3TAS1R1
SCHEMBL6316278 0.78 RECQL (0.46) RECQLLMNAADORA2ATSHRTAS1R3
SCHEMBL6319161 0.78 TAS1R3 (0.47) RECQLLMNATSHRTAS1R3TAS1R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050059657-A1 Aminoisoxazole derivatives active as kinase inhibitors PFIZER ITALIA S.R.L. (IT) 2005-03-17 US claimed
US-20050059657-A1 Aminoisoxazole derivatives active as kinase inhibitors PFIZER ITALIA S.R.L. (IT) 2005-03-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050059657-A1 Aminoisoxazole derivatives active as kinase inhibitors MAP3K9, MAP3K19, MAP4K2 RECQL 2512/4885LMNA 3334/4885SMN1; SMN2 2766/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.